Navigation Links
Novavax Reports First Quarter 2008 Financial Results
Date:5/9/2008

ROCKVILLE, Md., May 9 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the first quarter 2008. Novavax reported a net loss of $7.8 million ($0.13 loss per share) for the first quarter of 2008 compared to a net loss of $8.4 million ($0.14 loss per share) for the first quarter of 2007. Total cash and short-term investments as of March 31, 2008 were $40.9 million compared to $46.5 million as of December 31, 2007. The cash burn for the quarter was $5.6 million.

The following are key achievements during the quarter as well as additional plans for the balance of the year:

-- Commenced Phase IIa clinical studies for its H5N1 pandemic influenza

vaccine as a continuation of the original Phase I/IIa trial which

started last year. An interim analysis in December 2007 was favorable,

indicating that this vaccine demonstrated immunogenicity at 15

microgram and 45 microgram dose levels and was well tolerated. The

Company remains on plan to report preliminary immunogenicity results

from the dose-ranging portion of this Phase IIa study in late third

quarter/early fourth quarter of 2008.

-- Continued as planned to advance its seasonal influenza vaccine program

through pre-clinical studies with a target of commencing human trials

in a Phase IIa study in early third quarter of 2008. The Company

believes the initial results from the pandemic influenza vaccine study

bode well for the seasonal program. It is important to note the safety

data generated in the ongoing Phase I/IIa H5N1 pandemic influenza study

will be used to support the safety database for our seasonal program

which will allow us to begin human trials for this program with a Phase

IIa trial.

-- Pending a successful outcome of the Phase IIa trial, an additional

Phase IIb trial of our seasonal infl
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Oven Industries announces the new 5R1-1400 ... or via a PC through the TTL level UART ... half inches square can deliver up to 15 AMPS ... noise solid state relay. Operator safety is achieved with ... port and sensor input. Specifications: Input Voltage 85 ...
(Date:5/22/2013)... iLuv Creative Technology, the premier provider ... mobile lifestyle, announces they are now shipping MultiCharger-X, an ... iPad devices efficiently. Winner of the 2013 internationally recognized ... award, MultiCharger-X is revolutionizing the way businesses, schools, and ... , MultiCharger-X (iAD910) combines the best ...
(Date:5/22/2013)... May 22, 2013 The Conference ... Disruptive Innovations to Advance Clinical Trials conference taking place ... in Boston, MA. , Disruptive thinkers from Novartis, ... more share bold approaches to reduce expensive infrastructure, engage ... innovation needs to be big, or novel, or it ...
(Date:5/22/2013)... , May 22, 2013  Empire Genomics ... for a patent pending novel genomic biomarker from ... diagnostic test that could help in diagnosing and ... cancer.  Neuroendocrine prostate cancer (NEPC) ... that can arise de novo, but more commonly ...
Breaking Biology Technology:New AC Temperature Controller Announced by Oven Industries 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Madison, Wis. John Hawks has a cardinal rule ... write it down." , ,The University of Wisconsin-Madison anthropologist practices ... it down, but share it with the world via academic ... that solved Hawks' practical academic needs and also happened to ...
... ago, we talked about Venture Capital investments during 2005 in ... compared against the general VC landscape. I also promised to ... region and stage of development for 2005. , ,The information ... by PriceWaterhouse Cooper's MoneyTree Survey . It is also ...
... making navigation and medical devices will receive funding ... of Commerce Technology Venture Fund program. ... to develop a navigational tool for firefighters. It ... services necessary to complete preliminary prototype development services. ...
Cached Biology Technology:Anthropology professor's blog raises public interest 2Anthropology professor's blog raises public interest 3Midwest plays small role in VC investment, angel groups to the rescue 2Midwest plays small role in VC investment, angel groups to the rescue 3Midwest plays small role in VC investment, angel groups to the rescue 4Midwest plays small role in VC investment, angel groups to the rescue 5
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... University of Michigan Water Center today awarded 12 ... Lakes restoration and protection efforts. , The two-year ... projects, including efforts to track the remediation of ... to control non-native weedy plant invasions; study chromosomal ... responses to restoration activities. , The grants were ...
(Date:5/21/2013)... Think keeping in shape is an uphill battle? Try ... and prolonged weightlessness withers muscle and bone. , That,s ... will address with a new three-year, $1.2 million grant ... to exercise during multiyear exploratory missions. , "You could ... if you can,t get them to stick to it, ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Fueling fitness on the final frontier 2
... As part of its 50th anniversary events, the University ... celebrating 21 years of continuous support for research in ... conference. Citizen Science Past, Present & Future, ... of Lifelong Learning, will showcase longstanding research from the ...
... throughout the world stand to benefit from a new ... Australia that aims to develop more advanced fertilizers ... Technology Research Centre, to be based at the University ... facilities. The new centre has been established by ...
... ANN ARBOR, Mich.---Did modern birds originate around the time ... far longer" The question is at the ... between paleontologists, whose estimates are based on the fossil ... study evolutionary history. A new analysis by researchers ...
Cached Biology News:Citizen Science -- a celebration of partnership between academia and local people 2Fertilizer research center an Australian first 2Avian origins: new analysis confirms ancient beginnings 2
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case ...
Gelatin 100 mm Culture Dishes...
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
... an internal standard for the quantification of ... 5-OxoETE is a polyunsaturated keto acid formed ... neutrophils. It stimulates cytosolic calcium levels in ... 5-OxoETE selectively stimulates the migration and degranulation ...
Biology Products: